Savara Inc.
USD6.09
+0.07 (+1.08%)
CEO
Matthew Pauls
IPO Date
2017-04-28
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$6.05
Prev. Close
$6.03
Day Low
$5.96
Day High
$6.17
52W Low
$1.98
52W High
$7.00
Market Cap
$1.25B
Volume
0.40M
| -6.3 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | -39.0% | -30.8% | 0.19 | 15.66 | -14.2 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | -35.4% | -27.3% | 0.24 | 21.98 | -6.2 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | -29.8% | -24.4% | 0.18 | 11.26 | -3.9 |
| 31 Dec 2020 | FY | -13533.5% | -19305.4% | -77.1% | -50.8% | 0.39 | 10.41 | -1.4 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | -76.9% | -57.4% | 0.25 | 11.40 | -2.3 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | -56.8% | -40.4% | 0.23 | 15.63 | -4.1 |
| 31 Dec 2017 | FY | 0.0% | 0.0% | -25.0% | -18.7% | 0.13 | 16.27 | -8.7 |
| 31 Dec 2016 | FY | 100.0% | -2730.8% | 30.4% | -37.8% | -0.12 | 4.23 | -2.7 |
| -10.4 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -31.3% | -21.0% | 0.32 | 7.65 | -6.5 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -25.2% | -18.6% | 0.25 | 11.08 | -4.1 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -18.0% | -14.1% | 0.20 | 14.91 | -5.6 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | -16.9% | -13.6% | 0.16 | 13.73 | -5.2 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -12.2% | -10.2% | 0.13 | 17.70 | -9.3 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | -21.9% | -15.9% | 0.26 | 11.31 | -9.5 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -16.7% | -12.9% | 0.22 | 14.90 | -10.9 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | -11.5% | -9.1% | 0.19 | 15.66 | -13.1 |